Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Milara, J. Lluch, P. Almudever, T. Peiró, A. Serrano, M. Alonso-Galicia, J. Freire, X. Qian, J. Cortijo (Valencia, Spain; Jersey City, United States Of America). Anti-inflammatory effects of roflumilast N-oxide and dexamethasone in human bronchial epithelial cells stimulated with toll-like receptor agonists. Eur Respir J 2013; 42: Suppl. 57, 3128

Member's Comments

No comment yet.

Related content which might interest you: Anti-inflammatory efficacy of formoterol via transrepressive mechanisms is independent of the glucocorticoid receptor in human bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 128s Year: 2004 Azithromycin augments rhinovirus-induced expression of IFNbeta and IFNλ1 in asthmatic bronchial epithelial cells by up-regulating RIG-I like receptors Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Anticholinergic treatment does not affect toll-like receptor 3-induced antiviral immune response in COPD bronchial epithelial cells Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Effects of JAK-STAT inhibitors on glucocorticosteroid resistant release of CXCR3 chemokines from human bronchial epithelial cells Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Modulating effect of carbocysteine on the membrane expression of toll-like receptor 4 on human bronchial epithelial cells Source: Annual Congress 2009 - Epithelial cell biology Year: 2009 Effect of retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Inhibitory effects of montelukast on mediator release by nasal epithelial cells from asthmatic subjects Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013 Differential effects of simvastatin and dexamethasone on TLR3-induced anti-viral cytokines in asthmatic epithelium Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Glucocorticoids and indacaterol regulated gene expressions profiling in human bronchial epithelial cells Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Protective effect of leukotriene receptor antagonist montelukast in bleomycin induced pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006 Protective effect of cysteinyl leukotriene receptor antagonist montelukast in bleomycin induced pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 111s Year: 2007 TNFα-induced glucocorticoid resistance: Effect of steroidal and non-steroidal GR agonists, formoterol and inhibition of inflammatory signalling Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012 Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Endothelin receptor antagonists (ERAs) neutralize LPS-induced cytokine release from pulmonary vascular smooth muscle cells (PVSMCs) by down-regulation of CD14 Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Effect of ambroxol and beclomethasone on LPS/TNF-alpha-induced neutrophil-related chemokines and nitrative stress in human bronchial epithelial cells Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 The effects of a cysteinyl leukotriene receptor antagonist, pranlukast, on dendritic cell chemoattractants in the airways of subjects with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 132s Year: 2004 IKKβ phosphorylation is modulated by the combination of glucocorticosteroids and long acting β2- agonists in Human Bronchial Epithelial (HBE) cells Source: Eur Respir J 2003; 22: Suppl. 45, 561s Year: 2003 Anti-inflammatory profile of N-acetylcysteine in human bronchi stimulated with lipopolysaccharide Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016